ArticleFrontiers in oncology2026
Effect of structured nursing care on treatment tolerance and quality of life in patients with esophageal cancer undergoing radiotherapy: a retrospective cohort study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the relationship between structured nursing care (SNC) and treatment tolerance in patients with esophageal cancer receiving radiotherapy (RT). Methods: This single-center retrospective cohort analysis included 120 patients with esophageal cancer who received definitive or adjuvant RT from January 2020 to December 2024. Patients received either standard nursing care (standard care) or SNC. The primary outcome was RT completion. Secondary outcomes included grade ≥2 toxicity, unplanned hospitalizations, weight change, and quality of life (QoL) as measured by the EORTC QLQ-C30 and QLQ-OES18. Multivariable logistic regression was performed to adjust for prespecified covariates. Results: The SNC group had a higher percentage of patients completing RT compared with the standard care group (89.5% vs 79.4%, p = 0.14). The incidence of grade ≥2 toxicity was lower in the SNC group (33.3% vs 50.8%, p = 0.048). Unplanned hospitalizations were also lower in the SNC group (7.0% vs 17.5%, p = 0.08). Weight loss was less pronounced in the SNC group (-1.7 ± 1.9 kg vs -2.8 ± 1.9 kg, p = 0.02). Descriptive QoL change data showed directionally more favorable patterns in the SNC group compared with the standard care group. In the adjusted analyses, SNC was associated with a higher odds of RT completion, but that association did not reach statistical significance (OR 2.09, 95% CI 0.69-6.30; p = 0.1899). Conclusion: SNC was associated with directional trends favoring treatment tolerance outcomes, although the adjusted association with completion of RT was not statistically significant. Therefore, these findings are exploratory in nature and warrant additional prospective studies evaluating structured supportive models of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.